Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals (AMLX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• AMLX last traded at $28.02, -2.91% on the day.
• Amylyx Pharmaceuticals: P/E -19.9, revenue $87.37M over the last four quarters.
• Over the past year AMLX returned 99.43%; year to date 131.95%.

Updated 2026-11-03 01:50 UTC